- Home
- / Nexalin Technology
Nexalin Technology
Stock Price
$2.6
2024-10-29
Market Capitalization
$27.6 M
2024-10-29
Revenue
$301.6 K
FY, 2025
Nexalin Technology Summary
Company Summary
- Overview
- Nexalin Technology is a company that designs and develops neurostimulation products. It offers Gen-1, a medical device that utilizes bioelectronic medical technology to treat anxiety and insomnia.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Houston, TX, US | view all locations
- Website
- https://nexalin.com/
- Cybersecurity rating
Table of Contents
Key People
David Owens, Chief Medical Officer, Board of Directors
Marilyn Elson, Chief Financial Officer
John Patrick Claude, Director of Engineering, Research and Development
LocationsView all
1 location detected
Houston, TX HQ
United States
1776 Yorktown Street suite 550a
Nexalin Technology Financials
Summary Financials
- Revenue (Q1, 2026)
- $15.0K
- Gross profit (Q1, 2026)
- $13.1K
- Net income (Q1, 2026)
- ($2.1M)
- Cash (Q1, 2026)
- $1.2M
- EBIT (Q1, 2026)
- ($2.1M)